Sana Biotechnology SANA Return on invested capital

Return on invested capital at other companies

Bristol-Myers SquibbBMY

16.7%+8.4pp

Vertex PharmaceuticalsVRTX

28.4%+1.4pp

Gilead SciencesGILD

-6.7%-24.7pp

CRISPR TherapeuticsCRSP

-32.4%+6.6pp

Allogene TherapeuticsALLO

-51.3%-5.7pp

Ginkgo BioworksDNA

-40.3%-8.7pp

FAQ

What is Sana Biotechnology's return on invested capital?

Sana Biotechnology (SANA) reported return on invested capital of -157.6% in Q1 2026.

How has Sana Biotechnology's return on invested capital changed year-over-year?

Sana Biotechnology's return on invested capital decreased by 88.5% year-over-year, from -83.6% to -157.6%.

What is the long-term trend for Sana Biotechnology's return on invested capital?

Over 3 years (2022 to 2025), Sana Biotechnology's return on invested capital has grown at a 34.4% compound annual growth rate (CAGR), from -53.6% to -130%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.